| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |